Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.caprotec bioanalytics has appointed Rainer Metternich as the managing director, chief business officer and chief operating officer of the company.
Subscribe to our email newsletter
Berlin, Germany-based caprotec bioanalytics focuses on the commercialisation of its proprietary Capture Compound Mass Spectrometry (CCMS) technology.
Prior to joining caprotec, Metternich was the vice president and head of Basic Research Site at Merck & Co in West Point, PA.
Before joining Meck, Metternich was the executive vice president and member of the executive committee at Schering AG in Berlin.
caprotec founder and CEO Hubert Koster said that they are delighted to have him join caprotec’s management team. His leadership experience, comprehensive knowledge of the drug discovery and development process, and international research network are exactly what we need for the future growth of our company.”